Cystic fibrosis papers of the year 2009.
作者信息
Balfour-Lynn Ian M
机构信息
Department of Paediatric Respiratory Medicine, Royal Brompton & Harefield NHS Foundation Trust, Sydney Street, London SW3 6NP, UK.
出版信息
J R Soc Med. 2010 Jul;103 Suppl 1(Suppl 1):S6-14. doi: 10.1258/jrsm.2010.s11003.
Abstract
摘要
相似文献
1
Cystic fibrosis papers of the year 2009.
J R Soc Med. 2010 Jul;103 Suppl 1(Suppl 1):S6-14. doi: 10.1258/jrsm.2010.s11003.
2
Pulse intravenous methylprednisolone for resistant allergic bronchopulmonary aspergillosis in cystic fibrosis.
Pediatr Pulmonol. 2006 Feb;41(2):164-70. doi: 10.1002/ppul.20333.
3
Anti-IgE therapy for allergic bronchopulmonary aspergillosis in people with cystic fibrosis.
Cochrane Database Syst Rev. 2015 Nov 4(11):CD010288. doi: 10.1002/14651858.CD010288.pub3.
4
Anti-IgE therapy for allergic bronchopulmonary aspergillosis in people with cystic fibrosis.
Cochrane Database Syst Rev. 2013 Sep 17(9):CD010288. doi: 10.1002/14651858.CD010288.pub2.
5
Allergic bronchopulmonary aspergillosis and Aspergillus infection in cystic fibrosis.
Curr Opin Pulm Med. 2010 Nov;16(6):598-603. doi: 10.1097/MCP.0b013e32833e24a6.
6
Omalizumab in the management of steroid dependent allergic bronchopulmonary aspergillosis (ABPA) complicating cystic fibrosis.
Paediatr Respir Rev. 2013 Mar;14(1):22-4. doi: 10.1016/j.prrv.2012.11.004. Epub 2013 Jan 1.
7
Misdiagnosis of cystic fibrosis based on transient pancreatic insufficiency and elevated sweat chloride.
Klin Padiatr. 2015 Mar;227(2):96-7. doi: 10.1055/s-0034-1396821. Epub 2015 Mar 9.
8
[Cystic fibrosis and normal sweat chloride values: a case-report].
Rev Mal Respir. 2001 Sep;18(4 Pt 1):443-5.
9
Cystic fibrosis with normal sweat chloride concentration--case report.
Rev Hosp Clin Fac Med Sao Paulo. 2003 Sep-Oct;58(5):260-2. doi: 10.1590/s0041-87812003000500005. Epub 2003 Nov 11.
10
Normal sweat chloride values do not exclude the diagnosis of cystic fibrosis.
Am J Respir Crit Care Med. 1995 Nov;152(5 Pt 1):1736-7. doi: 10.1164/ajrccm.152.5.7582320.
本文引用的文献
1
Vitamin D supplementation for cystic fibrosis.
Cochrane Database Syst Rev. 2009 Oct 7(4):CD007298. doi: 10.1002/14651858.CD007298.pub2.
2
Bisphosphonates for osteoporosis in people with cystic fibrosis.
Cochrane Database Syst Rev. 2009 Oct 7(4):CD002010. doi: 10.1002/14651858.CD002010.pub2.
3
Vaccines for preventing influenza in people with cystic fibrosis.
Cochrane Database Syst Rev. 2009 Oct 7(4):CD001753. doi: 10.1002/14651858.CD001753.pub2.
4
Genetic modifiers of liver disease in cystic fibrosis.
JAMA. 2009 Sep 9;302(10):1076-83. doi: 10.1001/jama.2009.1295.
5
Therapeutic efficacy and safety of amitriptyline in patients with cystic fibrosis.
Cell Physiol Biochem. 2009;24(1-2):65-72. doi: 10.1159/000227814. Epub 2009 Jul 1.
6
Inhaled medication and inhalation devices for lung disease in patients with cystic fibrosis: A European consensus.
J Cyst Fibros. 2009 Sep;8(5):295-315. doi: 10.1016/j.jcf.2009.04.005. Epub 2009 Jun 25.
7
Intravenous monthly pulse methylprednisolone treatment for ABPA in patients with cystic fibrosis.
J Cyst Fibros. 2009 Jul;8(4):253-7. doi: 10.1016/j.jcf.2009.04.008. Epub 2009 May 15.
8
Lung disease at diagnosis in infants with cystic fibrosis detected by newborn screening.
Am J Respir Crit Care Med. 2009 Jul 15;180(2):146-52. doi: 10.1164/rccm.200901-0069OC. Epub 2009 Apr 16.
9
Cystic fibrosis pulmonary guidelines: airway clearance therapies.
Respir Care. 2009 Apr;54(4):522-37.
10
Phenotypic characterisation of patients with intermediate sweat chloride values: towards validation of the European diagnostic algorithm for cystic fibrosis.
Thorax. 2009 Aug;64(8):683-91. doi: 10.1136/thx.2008.104752. Epub 2009 Mar 23.
Zotero 插件